colgate-palmolive co. - CL

CL

Close Chg Chg %
94.28 -0.78 -0.83%

Closed Market

93.50

-0.78 (0.83%)

Volume: 4.11M

Last Updated:

Apr 16, 2025, 3:59 PM EDT

Company Overview: colgate-palmolive co. - CL

CL Key Data

Open

$94.65

Day Range

93.22 - 95.00

52 Week Range

85.35 - 109.29

Market Cap

$76.45B

Shares Outstanding

811.08M

Public Float

809.79M

Beta

0.40

Rev. Per Employee

N/A

P/E Ratio

26.86

EPS

$3.53

Yield

212.18%

Dividend

$0.52

EX-DIVIDEND DATE

Apr 17, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

5.54M

 

CL Performance

1 Week
 
-0.54%
 
1 Month
 
4.09%
 
3 Months
 
5.41%
 
1 Year
 
7.30%
 
5 Years
 
27.34%
 

CL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 25
Full Ratings ➔

About colgate-palmolive co. - CL

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

CL At a Glance

Colgate-Palmolive Co.
300 Park Avenue
New York, New York 10022-7499
Phone 1-212-310-2000 Revenue 20.10B
Industry Household/Personal Care Net Income 2.89B
Sector Consumer Non-Durables 2024 Sales Growth 3.31%
Fiscal Year-end 12 / 2025 Employees 34,000
View SEC Filings

CL Valuation

P/E Current 26.784
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 25.904
Price to Sales Ratio 3.723
Price to Book Ratio 348.448
Price to Cash Flow Ratio 18.222
Enterprise Value to EBITDA 16.525
Enterprise Value to Sales 4.101
Total Debt to Enterprise Value 0.103

CL Efficiency

Revenue/Employee 591,205.882
Income Per Employee 84,970.588
Receivables Turnover 13.216
Total Asset Turnover 1.239

CL Liquidity

Current Ratio 0.923
Quick Ratio 0.578
Cash Ratio 0.218

CL Profitability

Gross Margin 60.226
Operating Margin 21.805
Pretax Margin 19.681
Net Margin 14.372
Return on Assets 17.812
Return on Equity 703.776
Return on Total Capital 33.116
Return on Invested Capital 33.583

CL Capital Structure

Total Debt to Total Equity 4,015.094
Total Debt to Total Capital 97.57
Total Debt to Total Assets 53.047
Long-Term Debt to Equity 3,653.302
Long-Term Debt to Total Capital 88.778
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Colgate-palmolive Co. - CL

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
17.42B 17.97B 19.46B 20.10B
Sales Growth
+5.77% +3.13% +8.29% +3.31%
Cost of Goods Sold (COGS) incl D&A
7.13B 7.82B 8.21B 8.00B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
556.00M 545.00M 567.00M 605.00M
Depreciation
467.00M 465.00M 495.00M 530.00M
Amortization of Intangibles
89.00M 80.00M 72.00M 75.00M
COGS Growth
+9.02% +9.67% +4.98% -2.57%
Gross Income
10.29B 10.15B 11.25B 12.11B
Gross Income Growth
+3.62% -1.39% +10.85% +7.60%
Gross Profit Margin
+59.08% +56.49% +57.82% +60.23%
2021 2022 2023 2024 5-year trend
SG&A Expense
6.41B 6.57B 7.12B 7.72B
Research & Development
307.00M 320.00M 343.00M 355.00M
Other SG&A
6.10B 6.25B 6.78B 7.37B
SGA Growth
+6.39% +2.47% +8.45% +8.47%
Other Operating Expense
- - - -
-
Unusual Expense
630.00M 830.00M 328.00M 85.00M
EBIT after Unusual Expense
3.26B 2.75B 3.80B 4.30B
Non Operating Income/Expense
(52.00M) 72.00M (124.00M) (50.00M)
Non-Operating Interest Income
17.00M 14.00M 55.00M 67.00M
Equity in Earnings of Affiliates
12.00M 12.00M 17.00M 22.00M
Interest Expense
117.00M 167.00M 287.00M 292.00M
Interest Expense Growth
-26.88% +42.74% +71.86% +1.74%
Gross Interest Expense
120.00M 172.00M 299.00M 292.00M
Interest Capitalized
- 3.00M 5.00M 12.00M
Pretax Income
3.09B 2.66B 3.39B 3.96B
Pretax Income Growth
-15.36% -13.83% +27.52% +16.63%
Pretax Margin
+17.72% +14.80% +17.43% +19.68%
Income Tax
749.00M 693.00M 937.00M 907.00M
Income Tax - Current - Domestic
228.00M 199.00M 72.00M 188.00M
Income Tax - Current - Foreign
521.00M 494.00M 865.00M 719.00M
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
12.00M 12.00M 17.00M 22.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.34B 1.97B 2.46B 3.05B
Minority Interest Expense
172.00M 182.00M 155.00M 160.00M
Net Income
2.17B 1.78B 2.30B 2.89B
Net Income Growth
-19.63% -17.59% +28.85% +25.61%
Net Margin Growth
+12.43% +9.93% +11.82% +14.37%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.17B 1.78B 2.30B 2.89B
Preferred Dividends
- - - -
-
Net Income Available to Common
2.17B 1.78B 2.30B 2.89B
EPS (Basic)
2.5633 2.1342 2.7798 3.527
EPS (Basic) Growth
-18.51% -16.74% +30.25% +26.88%
Basic Shares Outstanding
845.00M 836.40M 827.40M 819.10M
EPS (Diluted)
2.5533 2.128 2.7738 3.5095
EPS (Diluted) Growth
-18.59% -16.66% +30.35% +26.52%
Diluted Shares Outstanding
848.30M 838.80M 829.20M 823.20M
EBITDA
4.44B 4.13B 4.70B 4.99B
EBITDA Growth
-0.18% -7.02% +13.75% +6.17%
EBITDA Margin
+25.50% +22.99% +24.15% +24.81%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 99.35
Number of Ratings 25 Current Quarters Estimate 0.934
FY Report Date 06 / 2025 Current Year's Estimate 3.679
Last Quarter’s Earnings 0.86 Median PE on CY Estimate N/A
Year Ago Earnings 3.60 Next Fiscal Year Estimate 3.975
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 18 18 21 21
Mean Estimate 0.93 0.93 3.68 3.98
High Estimates 0.97 0.96 3.81 4.13
Low Estimate 0.90 0.90 3.55 3.85
Coefficient of Variance 1.79 1.85 1.49 1.99

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 12
OVERWEIGHT 2 2 1
HOLD 9 9 9
UNDERWEIGHT 1 1 2
SELL 1 1 2
MEAN Overweight Overweight Overweight

Insider Actions for Colgate-palmolive Co. - CL

Date Name Shares Transaction Value
Apr 4, 2025 Brian O. Newman Director 2,597 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share 238,898.03
Apr 4, 2025 John P. Bilbrey Director 33,688 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share 3,098,959.12
Apr 4, 2025 Lorrie M. Norrington Director 36,002 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share 3,311,823.98
Feb 28, 2025 Sally Massey Chief Human Resources Officer 14,805 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $92.02 per share 1,362,356.10
Nov 8, 2024 Stanley J. Sutula Chief Financial Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Nov 8, 2024 Stanley J. Sutula Chief Financial Officer 82,136 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $77.04 per share 6,327,757.44
Nov 8, 2024 Stanley J. Sutula Chief Financial Officer 36,726 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $94.11 per share 3,456,283.86
Oct 4, 2024 Lisa M. Edwards Director 14,012 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.24 per share 1,474,622.88
Sep 13, 2024 Gregory Malcolm EVP and Controller 9,974 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $106.84 per share 1,065,622.16
Aug 9, 2024 Sally Massey Chief Human Resources Officer 13,942 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $103.28 per share 1,439,929.76
Aug 9, 2024 Sally Massey Chief Human Resources Officer 15,851 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 9, 2024 John W. Kooyman Chief of Staff 3,191 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $102.88 per share 328,290.08
Aug 9, 2024 Gregory Malcolm EVP and Controller N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 9, 2024 John W. Kooyman Chief of Staff 27,972 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $72.29 per share 2,022,095.88
Aug 9, 2024 Gregory Malcolm EVP and Controller 10,377 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $103.1 per share 1,069,868.70
Aug 9, 2024 John W. Kooyman Chief of Staff N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Jennifer M. Daniels CLO and Secretary 81,948 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $72.29 per share 5,924,020.92
May 17, 2024 Jennifer M. Daniels CLO and Secretary 59,698 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $94.15 per share 5,620,566.70
May 17, 2024 Jennifer M. Daniels CLO and Secretary 44,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 16, 2024 John T. Cahill Director 26,890 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Colgate-Palmolive Co. in the News

ZipRecruiter IPO: 5 things to know

ZipRecruiter is taking its business to the next level and is Wall Street's newest public company ready to cash in on the tight job market.